Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ASP IsotopesASPI -3.42%41 Future 3-5Y EPS without NRI Growth Rate is 23.11 as of Aug. 21, 2026. GuruFocus rates ASPI with a GF Score™ of 41/100 and a GF Value™ of $23.04 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 324 Chemicals companies, ASP Isotopes ranks better than 52.16% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
As of today, ASP Isotopes's Future 3-5Y EPS without NRI Growth Rate is 23.11.
ASP Isotopes (NAS:ASPI) Future 3-5Y EPS without NRI Growth Rate Explanation
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
ASP Isotopes Future 3-5Y EPS without NRI Growth Rate Related Terms
ASPI vs RYAM, ASIX, VHI: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Chemicals subindustry, ASP Isotopes's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASP Isotopes Future 3-5Y EPS without NRI Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, ASP Isotopes's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where ASP Isotopes's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 23.11 mean?
ASP Isotopes (ASPI) has a Future 3-5Y EPS without NRI Growth Rate of 23.11 as of Aug. 21, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for ASP Isotopes and its competitors. According to the industry distribution chart, ASP Isotopes ranks #155 out of 324 companies in the Chemicals industry, placing it in the top 47.8%.
Is ASP Isotopes' Future 3-5Y EPS without NRI Growth Rate too high?
ASP Isotopes' current Future 3-5Y EPS without NRI Growth Rate is 23.11. The Chemicals industry median Future 3-5Y EPS without NRI Growth Rate is 22.18. ASP Isotopes' value of 23.11 is 4.2% above this industry median. Based on the distribution chart, ASP Isotopes ranks #155 out of 324 companies in the Chemicals industry, which is above the industry midpoint. Overall, ASP Isotopes has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ASP Isotopes' Future 3-5Y EPS without NRI Growth Rate compare to RYAM and ASIX?
According to the Chemicals industry distribution chart, ASP Isotopes ranks #155 out of 324 companies for Future 3-5Y EPS without NRI Growth Rate. This puts ASP Isotopes in the upper half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 22.18. ASP Isotopes' value of 23.11 is 4.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Chemicals company?
The median Future 3-5Y EPS without NRI Growth Rate among Chemicals companies is 22.18, based on 324 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ASP Isotopes's current Future 3-5Y EPS without NRI Growth Rate of 23.11 is 4.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for ASP Isotopes and its competitors. For the Chemicals industry, the median Future 3-5Y EPS without NRI Growth Rate is 22.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ASP Isotopes's current Future 3-5Y EPS without NRI Growth Rate is 23.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASP Isotopes stock overvalued right now?
Based on GuruFocus' analysis, ASP Isotopes (ASPI) is currently considered Possible Value Trap. The stock's GF Value™ is $23.04, compared to a current price of $3.95 — trading 82.9% below its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 23.11 and 4.2% above the Chemicals industry median of 22.18. ASP Isotopes' overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For ASP Isotopes (ASPI), the current Future 3-5Y EPS without NRI Growth Rate is 23.11 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ASP Isotopes (ASPI) Overvalued in 2026?
Based on GuruFocus' analysis, ASP Isotopes stock appears to be undervalued.
The current stock price of $3.95 is trading 82.9% below its estimated GF Value™ of $23.04.
GuruFocus considers ASP Isotopes to be Possible Value Trap.
Key valuation signals for ASPI:
Future 3-5Y EPS without NRI Growth Rate: 23.11
GF Value™: $23.04 vs. price of $3.95 (82.9% below fair value)
Industry Position: 4.2% above the Chemicals median (#155 of 324)
No single metric tells the full story. See the ASPI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.
41GF Score
Get the complete analysis for ASPI
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASPI has been successfully added to your 
